Short Term Trends:
Bounties on specific illness, i.e €800m to develop a drug to treat bird flu.
Long Term Trends:
Break up of the pharmaceutical value chain, research, clinical trials and manufacturing will split.
Wednesday 20 June 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment